reported a novel cerasome nanoparticle decorated with cetuximab, an anti-EGFR antibody, IRDye800CW, and MRI contrast DOTA-Gd to enable in vivo tumor detection and PDT. The gene discussed is EGFR; the disease is neoplasm.